IFN‐α enhances CD40 ligand‐mediated activation of immature monocyte‐derived dendritic cells

Type I IFN are immune modulatory cytokines that are secreted during early stages of infection. Type I IFN bridge the innate and the adaptive immune system in humans and mice. We compared the capacity of type I and II IFN to induce the functional maturation of monocyte-derived dendritic cells (MoDC). Extending our earlier observation that type I IFN promote DC maturation, we report that these cytokines also enhance DC differentiation by augmenting CD40 ligand (CD40L)-induced cytokine secretion by MoDC. Type I IFN alone were poor inducers of MoDC maturation as compared with other stimuli. They up-regulated the expression of HLA-DR, CD80, CD86, partially CCR7 but not CD83, partially reduced antigen-uptake function, increased the levels of IL-12p35 mRNA, and prolonged surface expression of peptide-MHC class I complexes for presentation to cytotoxic T lymphocytes, but did not induce migration towards CCL21 chemokine. However, type I IFN were potent co-factors for CD40L-mediated function. Here, they enhanced CD40L-mediated IL-6, IL-10 and IL-12p70 secretion. Furthermore, when combined with IL-1beta and/or IL-4, IFN-alpha2a type I IFN increased CD40L-mediated IL-12p70 production by 2- to 3-fold, and biased the IL-12 p40/p70 ratio towards the IFN-gamma inducing p70 heterodimer, this correlating with higher levels of IFN-gamma secretion by allogeneic T cell subsets and NK cells. Our results suggest that the rapid expression of CD40L, IFN and IL-1beta at sites of infection and inflammation can act in concert on immature DC, thereby linking innate and adaptive immune responses. In this way, type I IFN play a dual role as DC maturation factors and enhancers of CD40L-mediated DC activation.

[1]  T. Luft,et al.  IL-1β Enhances CD40 Ligand-Mediated Cytokine Secretion by Human Dendritic Cells (DC): A Mechanism for T Cell-Independent DC Activation1 , 2002, The Journal of Immunology.

[2]  T. Luft,et al.  Exogenous Peptides Presented by Transporter Associated with Antigen Processing (TAP)-Deficient and TAP-Competent Cells: Intracellular Loading and Kinetics of Presentation1 , 2001, The Journal of Immunology.

[3]  A. Galy,et al.  IL-1β induces dendritic cells to produce IL-12 , 2001 .

[4]  S. Ikehara,et al.  Differential Regulation of Human Blood Dendritic Cell Subsets by IFNs1 , 2001, The Journal of Immunology.

[5]  Manfred Herold,et al.  Production of IL-12 by Human Monocyte-Derived Dendritic Cells Is Optimal When the Stimulus Is Given at the Onset of Maturation, and Is Further Enhanced by IL-41 , 2001, The Journal of Immunology.

[6]  I. Mellman,et al.  CHAPTER 16 – Studies of endocytosis , 2001 .

[7]  R. Steinman,et al.  Will the Making of Plasmacytoid Dendritic Cells in Vitro Help Unravel Their Mysteries? , 2000, The Journal of experimental medicine.

[8]  T. Luft,et al.  Interleukin (Il)-4 Is a Major Regulatory Cytokine Governing Bioactive IL-12 Production by Mouse and Human Dendritic Cells , 2000, The Journal of experimental medicine.

[9]  Mark M. Davis,et al.  Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia , 2000, Nature Medicine.

[10]  H. Smits,et al.  IL-4 Is a Mediator of IL-12p70 Induction by Human Th2 Cells: Reversal of Polarized Th2 Phenotype by Dendritic Cells1 , 2000, The Journal of Immunology.

[11]  N. Kadowaki,et al.  Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity , 2000, The Journal of experimental medicine.

[12]  T. Di Pucchio,et al.  Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice , 2000, The Journal of experimental medicine.

[13]  M. Lotze,et al.  IFN-α-Expressing Tumor Cells Enhance Generation and Promote Survival of Tumor-Specific CTLs , 2000, The Journal of Immunology.

[14]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[15]  D. Jarrossay,et al.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.

[16]  H. Messner,et al.  Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha. , 1999, Experimental hematology.

[17]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[18]  M. Goldman,et al.  IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[19]  M. Eloranta,et al.  Splenic Marginal Metallophilic Macrophages and Marginal Zone Macrophages are the Major Interferon‐α/β Producers in Mice upon Intravenous Challenge with Herpes Simplex Virus , 1999 .

[20]  P. Koskinen,et al.  Interferon- Activates Multiple STAT Proteins and Upregulates Proliferation-Associated IL-2R, c-myc, and pim-1 Genes in Human T Cells , 1999 .

[21]  P. Kalinski,et al.  Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. , 1999, Journal of immunology.

[22]  F. Sallusto,et al.  Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation , 1999, The Journal of experimental medicine.

[23]  B. Bergamasco,et al.  Autoimmune events during interferon beta-1b treatment for multiple sclerosis , 1999, Journal of the Neurological Sciences.

[24]  S. Szabo,et al.  T helper differentiation proceeds through Stat1-dependent, Stat4-dependent and Stat4-independent phases. , 1999, Current topics in microbiology and immunology.

[25]  J. Sprent,et al.  The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice. , 1998, Cancer research.

[26]  M. Biffi,et al.  References Subscriptions Permissions Email Alerts The Role of Stat4 in Species-Specific Regulation of Th Cell Development by Type I , 2013 .

[27]  P. Kalinski,et al.  High-level IL-12 production by human dendritic cells requires two signals. , 1998, International immunology.

[28]  D. Radzioch,et al.  Acquired Resistance but Not Innate Resistance toMycobacterium bovis Bacillus Calmette-Guérin Is Compromised by Interleukin-12 Ablation , 1998, Infection and Immunity.

[29]  P. Fitzgerald-Bocarsly,et al.  The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses. , 1998, Journal of immunology.

[30]  P. Hermann,et al.  IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression. , 1998, Journal of immunology.

[31]  P. Libby,et al.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.

[32]  G. Davis,et al.  Intrahepatic hepatitis C virus–specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C , 1998, Hepatology.

[33]  M Kurimoto,et al.  Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. , 1998, Journal of immunology.

[34]  G. V. van Seventer,et al.  Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. , 1998, Journal of immunology.

[35]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[36]  P. Romero,et al.  Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. , 1998, Journal of immunology.

[37]  Reinhold Förster,et al.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.

[38]  T. Taniguchi,et al.  Type I interferons are essential mediators of apoptotic death in virally infected cells , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[39]  Fultz Mj,et al.  Analysis of the antagonist effect of IFN-alpha on IFN-gamma-induced interferon consensus sequence binding protein messenger RNA in murine macrophages. , 1998 .

[40]  J. Waring,et al.  Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias , 1998 .

[41]  R. Neville,et al.  Proliferation and extracellular matrix production by human infragenicular smooth muscle cells in response to interleukin-1 beta. , 1997, Journal of vascular surgery.

[42]  H. Klocker,et al.  Prostaglandin E2 and Tumor Necrosis Factor ␣ Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production , 1997 .

[43]  M. Manns,et al.  Viral induction of autoimmunity: mechanisms and examples in hepatology , 1997, Journal of viral hepatitis.

[44]  P. Ricciardi-Castagnoli,et al.  Production of Interferon‐α/β by Murine Dendritic Cell Lines Stimulated by Virus and Bacteria , 1997, Scandinavian journal of immunology.

[45]  P. Romero,et al.  Enhanced generation of specific tumor-reactive CTL in vitro by Melan-A/Mart-1 immunodominant peptide analogs , 1997 .

[46]  R. Rerko,et al.  In vivo production and function of IL-12 p40 homodimers. , 1997, Journal of immunology.

[47]  P. Libby,et al.  Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Biffi,et al.  Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells , 1997, The Journal of experimental medicine.

[49]  J. Orange,et al.  Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection , 1997 .

[50]  R. Rees,et al.  Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. , 1996, Journal of immunology.

[51]  C. Rinaldo,et al.  Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV-1 and herpes simplex virus. , 1996, Journal of immunology.

[52]  S. Hill,et al.  The pathogenesis of postinfectious myocarditis. , 1996, Clinical immunology and immunopathology.

[53]  C. Holt,et al.  Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease , 1996 .

[54]  K. Goodrum,et al.  Interleukin-12 and tumor necrosis factor alpha mediate innate production of gamma interferon by group B Streptococcus-treated splenocytes of severe combined immunodeficiency mice , 1996, Infection and immunity.

[55]  K. Murphy,et al.  Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. , 1996, Journal of immunology.

[56]  A. Takeshita,et al.  Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. , 1996, The Journal of clinical investigation.

[57]  R. Zinkernagel,et al.  Immune Defence in Mice Lacking Type I and/or Type II Interferon Receptors , 1995, Immunological reviews.

[58]  M. Tymms,et al.  A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. V. von Herrath,et al.  Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases. , 1995, Trends in microbiology.

[60]  R. Appelberg,et al.  Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. , 1995, Journal of immunology.

[61]  R. Kurlander,et al.  Analysis of the Interrelationship between IL-12, TNF-α, and IFN-γ/Production during Murine Listeriosis , 1995 .

[62]  T. Yue,et al.  Interleukin-1β induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells , 1995 .

[63]  M. Colombo,et al.  Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. , 1995, European journal of endocrinology.

[64]  C. Cheers,et al.  Endogenous interleukin-12 is involved in resistance to Brucella abortus infection , 1995, Infection and immunity.

[65]  A. Greenway,et al.  Constitutive and virus-induced interferon production by peripheral blood leukocytes. , 1995, Experimental hematology.

[66]  H. Gisslinger,et al.  Thyroid autoimmunity and hypothyroidism during long‐term treatment with recombinant interferon‐alpha , 1992, Clinical and experimental immunology.

[67]  K. Ozato,et al.  Modulation of interferon consensus sequence binding protein mRNA in murine peritoneal macrophages. Induction by IFN-gamma and down-regulation by IFN-alpha, dexamethasone, and protein kinase inhibitors. , 1992, Journal of immunology.

[68]  K. Öberg,et al.  Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment , 1991 .

[69]  D. Roncari,et al.  Possible mechanisms in the pathogenesis of virus-induced diabetes mellitus. , 1987, Clinical and investigative medicine. Medecine clinique et experimentale.

[70]  M. Warren,et al.  CSF-1-induced resistance to viral infection in murine macrophages. , 1987, Journal of immunology.

[71]  B. Rouse,et al.  Interferon Produced Endogenously in Response to CSF‐1 Augments the Functional Differentiation of Progeny Macrophages , 1985, Journal of leukocyte biology.